PATENT CLAIM ANALYSIS

Application Number: 15743546
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["546", "153000"]

Abstract:
Compounds that inhibit Myeloid Cell Leukemia-1 (Mcl-1) oncoprotein, and methods of using the same, are provided for treating disease.

Claim (Index 16):
A method of treating a condition by inhibiting Mcl-1 protein activity in a patient in need of said treatment, the method comprising administering a therapeutically effective amount of a compound of  claim 8  or a pharmaceutically acceptable salt, solvate, hydrate, cocrystal, or prodrug thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.04348
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12104294', '12096393', '14763468', '13823810', '13526337']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7410582397086083
- 35 USC 102 Novelty (BERT): 0.5092157181537709
- Combined Prediction Score: 0.7178739875531245
- Mean Citation Score: 268.77087199999994
- Max Citation Score: 276.15472
- Similarity Product: 203.59288642206192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test